COL11A2
Basic information
Region (hg38): 6:33162681-33192499
Previous symbols: [ "DFNA13", "DFNB53" ]
Links
Phenotypes
GenCC
Source:
- autosomal dominant nonsyndromic hearing loss 13 (Moderate), mode of inheritance: AD
- autosomal recessive nonsyndromic hearing loss 53 (Moderate), mode of inheritance: AR
- otospondylomegaepiphyseal dysplasia, autosomal dominant (Strong), mode of inheritance: AD
- otospondylomegaepiphyseal dysplasia, autosomal recessive (Strong), mode of inheritance: AR
- otospondylomegaepiphyseal dysplasia, autosomal recessive (Definitive), mode of inheritance: AR
- autosomal dominant nonsyndromic hearing loss 13 (Definitive), mode of inheritance: AD
- autosomal recessive nonsyndromic hearing loss 53 (Definitive), mode of inheritance: AR
- otospondylomegaepiphyseal dysplasia, autosomal dominant (Definitive), mode of inheritance: AD
- otospondylomegaepiphyseal dysplasia, autosomal dominant (Strong), mode of inheritance: AD
- autosomal recessive nonsyndromic hearing loss 53 (Moderate), mode of inheritance: AR
- otospondylomegaepiphyseal dysplasia, autosomal dominant (Moderate), mode of inheritance: AD
- otospondylomegaepiphyseal dysplasia, autosomal recessive (Moderate), mode of inheritance: AR
- otospondylomegaepiphyseal dysplasia (Supportive), mode of inheritance: AR
- fibrochondrogenesis (Supportive), mode of inheritance: AD
- autosomal dominant nonsyndromic hearing loss (Supportive), mode of inheritance: AD
- hearing loss, autosomal recessive (Supportive), mode of inheritance: AR
- otospondylomegaepiphyseal dysplasia, autosomal dominant (Supportive), mode of inheritance: AD
- otospondylomegaepiphyseal dysplasia, autosomal recessive (Strong), mode of inheritance: AR
- autosomal dominant nonsyndromic hearing loss 13 (Limited), mode of inheritance: AD
- autosomal recessive nonsyndromic hearing loss 53 (Strong), mode of inheritance: AR
- autosomal dominant nonsyndromic hearing loss 13 (Strong), mode of inheritance: AD
- otospondylomegaepiphyseal dysplasia, autosomal dominant (Strong), mode of inheritance: AD
- nonsyndromic genetic hearing loss (Definitive), mode of inheritance: AD
- otospondylomegaepiphyseal dysplasia (Definitive), mode of inheritance: AD
- otospondylomegaepiphyseal dysplasia (Definitive), mode of inheritance: AR
- nonsyndromic genetic hearing loss (Moderate), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Deafness, autosomal dominant 13; Otospondylomegaepiphyseal dysplasia, autosomal dominant (Stickler syndrome, type III/Weissenbacher-Zweymuller syndrome); Fibrochondrogenesis 2; Otospondylomegaepiphyseal dysplasia, autosomal recessive; Deafness, autosomal recessive 53 | AD/AR | Audiologic/Otolaryngologic; Ophthalmologic | Though the condition may be recognizable, early recognition and treatment of hearing impairment may improve outcomes, including speech and language development; Avoidance of risk factors related to ocular manifestations (eg, contact sports) is indicated | Audiologic/Otolaryngologic; Craniofacial; Musculoskeletal; Ophthalmologic | 14234962; 7833911; 7859284; 9805126; 9506662; 10581026; 10677296; 15372529; 16033917; 22246659; 25633957 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (70 variants)
- Otospondylomegaepiphyseal dysplasia, autosomal recessive (8 variants)
- Otospondylomegaepiphyseal dysplasia, autosomal dominant (2 variants)
- Otospondylomegaepiphyseal dysplasia, autosomal recessive;Autosomal dominant nonsyndromic hearing loss 13;Autosomal recessive nonsyndromic hearing loss 53;Fibrochondrogenesis 2;Otospondylomegaepiphyseal dysplasia, autosomal dominant (1 variants)
- Autosomal dominant nonsyndromic hearing loss 13 (1 variants)
- Fibrochondrogenesis 2 (1 variants)
- Autosomal recessive nonsyndromic hearing loss 53 (1 variants)
- Nonsyndromic Deafness (1 variants)
- See cases (1 variants)
- COL11A2-related disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the COL11A2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 16 | 484 | 11 | 511 | ||
missense | 557 | 136 | 22 | 728 | ||
nonsense | 25 | 15 | 40 | |||
start loss | 1 | |||||
frameshift | 44 | 56 | ||||
inframe indel | 12 | 12 | ||||
splice donor/acceptor (+/-2bp) | 26 | 29 | ||||
splice region | 1 | 2 | 79 | 164 | 3 | 249 |
non coding | 27 | 568 | 92 | 687 | ||
Total | 75 | 59 | 617 | 1188 | 125 |
Highest pathogenic variant AF is 0.0000132
Variants in COL11A2
This is a list of pathogenic ClinVar variants found in the COL11A2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-33162753-C-T | Otospondylomegaepiphyseal dysplasia, autosomal dominant • Fibrochondrogenesis 2 • Otospondylomegaepiphyseal dysplasia, autosomal recessive • Stickler Syndrome, Dominant | Likely benign (Jan 13, 2018) | ||
6-33162856-G-C | Otospondylomegaepiphyseal dysplasia, autosomal dominant • Otospondylomegaepiphyseal dysplasia, autosomal recessive • Fibrochondrogenesis 2 • Stickler Syndrome, Dominant | Conflicting classifications of pathogenicity (Jan 13, 2018) | ||
6-33162859-G-A | Otospondylomegaepiphyseal dysplasia, autosomal recessive • Otospondylomegaepiphyseal dysplasia, autosomal dominant • Fibrochondrogenesis 2 | Uncertain significance (Apr 27, 2017) | ||
6-33162890-T-G | Otospondylomegaepiphyseal dysplasia, autosomal recessive • Otospondylomegaepiphyseal dysplasia, autosomal dominant • Fibrochondrogenesis 2 | Uncertain significance (Jan 12, 2018) | ||
6-33162972-C-A | Fibrochondrogenesis 2 • Otospondylomegaepiphyseal dysplasia, autosomal recessive • Otospondylomegaepiphyseal dysplasia, autosomal dominant • Stickler Syndrome, Dominant | Conflicting classifications of pathogenicity (Jan 13, 2018) | ||
6-33163134-G-C | Stickler Syndrome, Dominant • Otospondylomegaepiphyseal dysplasia, autosomal recessive • Otospondylomegaepiphyseal dysplasia, autosomal dominant • Fibrochondrogenesis 2 | Uncertain significance (Jan 12, 2018) | ||
6-33163142-G-A | Stickler Syndrome, Dominant • Otospondylomegaepiphyseal dysplasia, autosomal recessive • Otospondylomegaepiphyseal dysplasia, autosomal dominant • Fibrochondrogenesis 2 | Uncertain significance (Jan 12, 2018) | ||
6-33163193-C-G | Otospondylomegaepiphyseal dysplasia, autosomal recessive • Otospondylomegaepiphyseal dysplasia, autosomal dominant • Fibrochondrogenesis 2 | Uncertain significance (Jan 12, 2018) | ||
6-33163239-G-T | Stickler Syndrome, Dominant • Otospondylomegaepiphyseal dysplasia, autosomal dominant • Otospondylomegaepiphyseal dysplasia, autosomal recessive • Fibrochondrogenesis 2 | Uncertain significance (Jan 13, 2018) | ||
6-33163249-C-A | Otospondylomegaepiphyseal dysplasia, autosomal dominant • Otospondylomegaepiphyseal dysplasia, autosomal recessive • Fibrochondrogenesis 2 | Uncertain significance (Jan 13, 2018) | ||
6-33163285-T-C | Otospondylomegaepiphyseal dysplasia, autosomal dominant • Fibrochondrogenesis 2 • Otospondylomegaepiphyseal dysplasia, autosomal recessive | Uncertain significance (Jan 15, 2018) | ||
6-33163430-G-T | Fibrochondrogenesis 2 • Otospondylomegaepiphyseal dysplasia, autosomal recessive • Otospondylomegaepiphyseal dysplasia, autosomal dominant • Stickler Syndrome, Dominant | Uncertain significance (Jan 12, 2018) | ||
6-33163550-G-C | Fibrochondrogenesis 2 • Otospondylomegaepiphyseal dysplasia, autosomal dominant • Stickler Syndrome, Dominant • Otospondylomegaepiphyseal dysplasia, autosomal recessive | Likely benign (Jan 12, 2018) | ||
6-33163559-C-T | Fibrochondrogenesis 2 • Otospondylomegaepiphyseal dysplasia, autosomal recessive • Stickler Syndrome, Dominant • Otospondylomegaepiphyseal dysplasia, autosomal dominant | Likely benign (Jan 13, 2018) | ||
6-33163667-CAG-C | Likely benign (Mar 01, 2022) | |||
6-33163674-G-A | not specified • Fibrochondrogenesis 2 • Stickler Syndrome, Dominant • Otospondylomegaepiphyseal dysplasia, autosomal dominant • Otospondylomegaepiphyseal dysplasia, autosomal recessive • Connective tissue disorder | Benign/Likely benign (Feb 14, 2024) | ||
6-33163679-T-C | Uncertain significance (Jul 23, 2022) | |||
6-33163685-A-G | Likely benign (Jan 22, 2024) | |||
6-33163686-T-A | Benign (Jan 08, 2024) | |||
6-33163694-A-G | not specified | Uncertain significance (Nov 13, 2023) | ||
6-33163695-C-G | Uncertain significance (Jul 19, 2022) | |||
6-33163698-G-A | Benign (Aug 17, 2023) | |||
6-33163699-C-G | Likely benign (Jun 09, 2023) | |||
6-33163704-G-A | Likely benign (Oct 20, 2023) | |||
6-33163710-C-A | Uncertain significance (Jun 04, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
COL11A2 | protein_coding | protein_coding | ENST00000374708 | 64 | 29819 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.702 | 0.298 | 125705 | 0 | 43 | 125748 | 0.000171 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.37 | 755 | 962 | 0.785 | 0.0000585 | 10101 |
Missense in Polyphen | 146 | 262.82 | 0.55552 | 2603 | ||
Synonymous | 1.01 | 333 | 357 | 0.932 | 0.0000213 | 3689 |
Loss of Function | 7.73 | 25 | 114 | 0.219 | 0.00000728 | 1238 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000276 | 0.000268 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000275 | 0.000272 |
Finnish | 0.0000465 | 0.0000462 |
European (Non-Finnish) | 0.000245 | 0.000237 |
Middle Eastern | 0.000275 | 0.000272 |
South Asian | 0.0000986 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May play an important role in fibrillogenesis by controlling lateral growth of collagen II fibrils.;
- Disease
- DISEASE: Otospondylomegaepiphyseal dysplasia, autosomal dominant (OSMEDA) [MIM:184840]: An autosomal dominant form of otospondylomegaepiphyseal dysplasia, a disorder characterized by sensorineural deafness, enlarged epiphyses, mild platyspondyly, and disproportionate shortness of the limbs. Total body length is normal. Typical facial features are mid-face hypoplasia, short upturned nose and depressed nasal bridge. Most patients have Pierre Robin sequence including an opening in the roof of the mouth (cleft palate) and a small lower jaw (micrognathia). Ocular symptoms are absent. Some patients have early-onset osteoarthritis. {ECO:0000269|PubMed:7859284, ECO:0000269|PubMed:9506662, ECO:0000269|PubMed:9805126}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Otospondylomegaepiphyseal dysplasia, autosomal recessive (OSMEDB) [MIM:215150]: An autosomal recessive form of otospondylomegaepiphyseal dysplasia, a disorder characterized by sensorineural deafness, enlarged epiphyses, mild platyspondyly, and disproportionate shortness of the limbs. Total body length is normal. Typical facial features are mid-face hypoplasia, short upturned nose and depressed nasal bridge. Most patients have Pierre Robin sequence including an opening in the roof of the mouth (cleft palate) and a small lower jaw (micrognathia). Ocular symptoms are absent. Some patients have early-onset osteoarthritis. {ECO:0000269|PubMed:10677296, ECO:0000269|PubMed:7859284}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Deafness, autosomal dominant, 13 (DFNA13) [MIM:601868]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:10581026}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Deafness, autosomal recessive, 53 (DFNB53) [MIM:609706]: A form of non-syndromic sensorineural deafness characterized by prelingual, profound, non-progressive hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:16033917, ECO:0000269|PubMed:25633957}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Fibrochondrogenesis 2 (FBCG2) [MIM:614524]: A severe skeletal dysplasia characterized by a flat midface, short long bones, short ribs with broad metaphyses, and vertebral bodies that show distinctive hypoplastic posterior ends and rounded anterior ends, giving the vertebral bodies a pinched appearance on lateral radiographic views. The chest is small, causing perinatal respiratory problems which usually, but not always, result in lethality. Affected individuals who survive the neonatal period have high myopia, mild to moderate hearing loss, and severe skeletal dysplasia. {ECO:0000269|PubMed:22246659}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Protein digestion and absorption - Homo sapiens (human);Neural Crest Differentiation;Focal Adhesion;Focal Adhesion-PI3K-Akt-mTOR-signaling pathway;Collagen chain trimerization;Collagen biosynthesis and modifying enzymes;Collagen formation;Extracellular matrix organization;Integrin;Beta1 integrin cell surface interactions;Syndecan-1-mediated signaling events;Integrins in angiogenesis
(Consensus)
Intolerance Scores
- loftool
- 0.0206
- rvis_EVS
- -1.05
- rvis_percentile_EVS
- 7.62
Haploinsufficiency Scores
- pHI
- 0.137
- hipred
- Y
- hipred_score
- 0.627
- ghis
- 0.572
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.427
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | Medium | Medium |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Col11a2
- Phenotype
- craniofacial phenotype; growth/size/body region phenotype; hearing/vestibular/ear phenotype; skeleton phenotype;
Zebrafish Information Network
- Gene name
- col11a2
- Affected structure
- chondrocyte
- Phenotype tag
- abnormal
- Phenotype quality
- disorganized
Gene ontology
- Biological process
- skeletal system development;sensory perception of sound;extracellular matrix organization;collagen fibril organization;cartilage development;roof of mouth development;soft palate development
- Cellular component
- extracellular region;collagen trimer;collagen type XI trimer;extracellular space;endoplasmic reticulum lumen;extracellular matrix;collagen-containing extracellular matrix
- Molecular function
- extracellular matrix structural constituent;protein binding;extracellular matrix structural constituent conferring tensile strength;protein binding, bridging;metal ion binding